Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 11, Pages 2480-2490
http://dx.doi.org/10.1100/2011/968479
Research Article

In Vivo Expression of Interleukin-37 Reduces Local and Systemic Inflammation in Concanavalin A-Induced Hepatitis

1Department of Pediatrics, Dr. von Hauner Children’s Hospital, Ludwig-Maximilians-University, 80337 Munich, Germany
2Department of Pediatric Surgery, Dr. von Hauner Children’s Hospital, Ludwig-Maximilians-University, 80337 Munich, Germany
3Institute of Pathology, Ludwig-Maximilians-University, 80337 Munich, Germany

Received 15 July 2011; Accepted 7 November 2011

Academic Editor: Giamila Fantuzzi

Copyright © 2011 Ana-Maria Bulau et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [59 citations]

The following is the list of published articles that have cited the current article.

  • Lijun Song, Feng Qiu, Yuchen Fan, Feng Ding, Huaxiang Liu, Qiang Shu, Weiwei Liu, and Xingfu Li, “Glucocorticoid Regulates Interleukin-37 in Systemic Lupus Erythematosus,” Journal of Clinical Immunology, vol. 33, no. 1, pp. 111–117, 2012. View at Publisher · View at Google Scholar
  • Jacques Banchereau, Virginia Pascual, and Anne O'Garra, “From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines,” Nature Immunology, vol. 13, no. 10, pp. 925–931, 2012. View at Publisher · View at Google Scholar
  • S. Tetè, D. Tripodi, M. Rosati, F. Conti, G. Maccauro, A. Saggini, E. Cianchetti, A. Caraffa, P. Antinolfi, E. Toniato, M.L. Castellani, P. Conti, and T.C. Theoharides, “IL-37 (IL-1F7) the Newest Anti-Inflammatory Cytokine Which Suppresses Immune Responses and Inflammation,” International Journal of Immunopathology and Pharmacology, vol. 25, no. 1, pp. 31–38, 2012. View at Publisher · View at Google Scholar
  • Gaëlle Clavel, Allan Thiolat, and Marie-Christophe Boissier, “Interleukin newcomers creating new numbers in rheumatology: IL-34 to IL-38,” Joint Bone Spine, 2013. View at Publisher · View at Google Scholar
  • Gaëlle Clavel, Allan Thiolat, and Marie-Christophe Boissier, “Les dernières interleukines pour de nouvelles fonctions en rhumatologie : de l’IL-34 à l’IL-38 ou « Les interleukines font leurs grands numéros »,” Revue du Rhumatisme, 2013. View at Publisher · View at Google Scholar
  • Cong Li, Huifan Ji, Yanjun Cai, Desalegn Admassu Ayana, Pin Lv, Maosheng Liu, and Yanfang Jiang, “Serum Interleukin-37 Concentrations and HBeAg Seroconversion in Chronic HBV Patients During Telbivudine Treatment,” Journal of Interferon & Cytokine Research, pp. 130522063847009, 2013. View at Publisher · View at Google Scholar
  • Xueting Shao, Yun Qian, Chenhuai Xu, Bo Hong, Wanhong Xu, Ling Shen, Changzhong Jin, Zhigang Wu, Xiangmin Tong, and Hangping Yao, “The Protective Effect of Intrasplenic Transplantation of Ad-IL-18BP/IL-4 Gene-Modified Fetal Hepatocytes on ConA-Induced Hepatitis in Mice,” Plos One, vol. 8, no. 3, 2013. View at Publisher · View at Google Scholar
  • Cong Li, Pingwei Zhao, Xiguang Sun, Yuanyuan Che, and Yanfang Jiang, “Elevated Levels of Cerebrospinal Fluid and Plasma Interleukin-37 in Patients with Guillain-Barré Syndrome,” Mediators of Inflammation, vol. 2013, pp. 1–9, 2013. View at Publisher · View at Google Scholar
  • Yanqun Li, Zi Wang, Ting Yu, Bingni Chen, Jinshun Zhang, Kunzhao Huang, and Zhong Huang, “Increased Expression of IL-37 in Patients with Graves' Disease and Its Contribution to Suppression of Proinflammatory Cytokines Production in Peripheral Blood Mononuclear Cells,” Plos One, vol. 9, no. 9, 2014. View at Publisher · View at Google Scholar
  • Simon Weidlich, Ana-Maria Bulau, Tobias Schwerd, Johanna Althans, Roland Kappler, Sibylle Koletzko, Doris Mayr, and Philip Bufler, “Intestinal Expression of the Anti-Inflammatory Interleukin-1 Homologue IL-37 in Pediatric Inflammatory Bowel Disease,” Journal of Pediatric Gastroenterology and Nutrition, vol. 59, no. 2, pp. e18–e26, 2014. View at Publisher · View at Google Scholar
  • Anton Kutikhin, and Arseniy Yuzhalinpp. 1–349, 2014. View at Publisher · View at Google Scholar
  • Jing-Jing Zhao, Qiu-Zhong Pan, Ke Pan, De-Sheng Weng, Qi-Jing Wang, Jian-Jun Li, Lin Lv, Dan-Dan Wang, Hai-Xia Zheng, Shan-Shan Jiang, Xiao-Fei Zhang, and Jian-Chuan Xia, “Interleukin-37 Mediates the Antitumor Activity in Hepatocellular Carcinoma: Role for CD57+ NK Cells,” Scientific Reports, vol. 4, 2014. View at Publisher · View at Google Scholar
  • Ping-Wei Zhao, Wei-Guang Jiang, Li Wang, Zhen-Yu Jiang, Yu-Xing Shan, and Yan-Fang Jiang, “Plasma Levels of IL-37 and Correlation with TNF-alpha, IL-17A, and Disease Activity during DMARD Treatment of Rheumatoid Arthritis,” Plos One, vol. 9, no. 5, 2014. View at Publisher · View at Google Scholar
  • Xiu Teng, Zhonglan Hu, Xiaoqiong Wei, Zhen Wang, Ting Guan, Ning Liu, Xiao Liu, Ning Ye, Guohua Deng, Can Luo, Nongyu Huang, Changyan Sun, Minyan Xu, Xikun Zhou, Hongxin Deng, Carl Keith Edwards, Xiancheng Chen, Xiaoxia Wang, Kaijun Cui, Yuquan Wei, and Jiong Li, “IL-37 Ameliorates the Inflammatory Process in Psoriasis by Suppressing Proinflammatory Cytokine Production,” Journal of Immunology, vol. 192, no. 4, pp. 1815–1823, 2014. View at Publisher · View at Google Scholar
  • Silvia Moretti, Silvia Bozza, Vasilis Oikonomou, Giorgia Renga, Andrea Casagrande, Rossana G. Iannitti, Matteo Puccetti, Cecilia Garlanda, Soohyun Kim, Suzhao Li, Frank L. van de Veerdonk, Charles A. Dinarello, and Luigina Romani, “IL-37 Inhibits Inflammasome Activation and Disease Severity in Murine Aspergillosis,” Plos Pathogens, vol. 10, no. 11, 2014. View at Publisher · View at Google Scholar
  • M. Sağlam, S. Köseoğlu, L. Savran, T. Pekbağriyanik, G. Sağlam, and R. Sütçü, “Levels of interleukin-37 in gingival crevicular fluid, saliva, or plasma in periodontal disease,” Journal of Periodontal Research, 2014. View at Publisher · View at Google Scholar
  • Shannon Quirk, and Devendra K Agrawal, “Immunobiology of IL-37: mechanism of action and clinical perspectives,” Expert Review of Clinical Immunology, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  • Y. Luo, X. Cai, S. Liu, S. Wang, C. A. Nold-Petry, M. F. Nold, P. Bufler, D. Norris, C. A. Dinarello, and M. Fujita, “Suppression of antigen-specific adaptive immunity by IL-37 via induction of tolerogenic dendritic cells,” Proceedings of the National Academy of Sciences, vol. 111, no. 42, pp. 15178–15183, 2014. View at Publisher · View at Google Scholar
  • Takeshi Suda, and Dexi Liu, “Hydrodynamic Delivery,” 2014. View at Publisher · View at Google Scholar
  • Xu Shuai, Li Wei-min, Ya-lin Tong, Ning Dong, Zhi-yong Sheng, and Yong-ming Yao, “Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T cells,” Scientific Reports, vol. 5, pp. 14478, 2015. View at Publisher · View at Google Scholar
  • Kenya Kamimura, Takeshi Yokoo, Hiroyuki Abe, Yuji Kobayashi, Kohei Ogawa, Yoko Shinagawa, Ryosuke Inoue, and Shuji Terai, “Image-guided hydrodynamic gene delivery: Current status and future directions,” Pharmaceutics, vol. 7, no. 3, pp. 213–223, 2015. View at Publisher · View at Google Scholar
  • Wei-qiang Wang, Kui Dong, Lu Zhou, Guo-hui Jiao, Cong-zhong Zhu, Wen-wen Li, Gang Yu, Wan-tong Wu, Song Chen, Zhi-na Sun, Yu-ming Wang, Wen-tian Liu, Jie Zhang, Bang-mao Wang, and Xiao-ming Feng, “IL-37b gene transfer enhances the therapeutic efficacy of mesenchumal stromal cells in DSS-induced colitis mice,” Acta Pharmacologica Sinica, 2015. View at Publisher · View at Google Scholar
  • J. H. Southcombe, C. W. G. Redman, I. L. Sargent, and I. Granne, “Interleukin-1 family cytokines and their regulatory proteins in normal pregnancy and pre-eclampsia,” Clinical & Experimental Immunology, 2015. View at Publisher · View at Google Scholar
  • W. Wu, W. Wang, Y. Wang, W. Li, G. Yu, Z. Li, C. Fang, Y. Shen, Z. Sun, L. Han, J. Yu, L. Fang, S. Chen, K. Dong, Z. Han, H. Liu, Y. Luo, and X. Feng, “IL-37b suppresses T cell priming by modulating dendritic cell maturation and cytokine production via dampening ERK/NF- B/S6K signalings,” Acta Biochimica et Biophysica Sinica, 2015. View at Publisher · View at Google Scholar
  • Mehrdad Farrokhi, Ali Rezaei, Ali Amani-Beni, Masoud Etemadifar, Ebrahim Kouchaki, and Abolfazl Zahedi, “Increased serum level of IL-37 in patients with multiple sclerosis and neuromyelitis optica,” Acta Neurologica Belgica, 2015. View at Publisher · View at Google Scholar
  • Tianshu Yang, Qing Lin, Mengmeng Zhao, Yongguang Hu, Ying Yu, Jiayi Jin, Hongyan Zhou, Xiao Hu, Rongbin Wei, Xuetao Zhang, Xiaoping Yang, Gaoqin Liu, Peirong Lu, Guotong Xu, Jianhua Yang, David B. Corry, Shao Bo Su, Shangfeng Liu, and Xialin Liu, “IL-37 Is a Novel Proangiogenic Factor of Developmental and Pathological Angiogenesis,” Arteriosclerosis Thrombosis And Vascular Biology, vol. 35, no. 12, pp. 2638–2646, 2015. View at Publisher · View at Google Scholar
  • Lars Lunding, Alexandra Schröder, and Michael Wegmann, “Allergic airway inflammation: unravelling the relationship between IL-37, IL-18Rα and Tir8/SIGIRR,” Expert Review of Respiratory Medicine, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  • Olivia Merkel, Kenya Kamimura, Takeshi Suda, and Dexi LiuAdvances and Challenges in the Delivery of Nucleic Acid Therapeutics (Volume 2), pp. 42–57, 2015. View at Publisher · View at Google Scholar
  • Jiajie Gu, Xueming Gao, Xiuhe Pan, Xiao Peng, Yan Li, and Mingcai Li, “High-level expression and one-step purification of a soluble recombinant human interleukin-37b in Escherichia coli,” Protein Expression and Purification, 2015. View at Publisher · View at Google Scholar
  • L. Lunding, S. Webering, C. Vock, A. Schröder, D. Raedler, B. Schaub, H. Fehrenbach, and M. Wegmann, “IL-37 requires IL-18Rα and SIGIRR/IL-1R8 to diminish allergic airway inflammation in mice,” Allergy, 2015. View at Publisher · View at Google Scholar
  • Frank L. van de Veerdonk, Mark S. Gresnigt, Marije Oosting, Jos W. M. van der Meer, Leo A. B. Joosten, Mihai G. Netea, and Charles A. Dinarello, “Protective host defense against disseminated candidiasis is impaired in mice expressing human interleukin-37,” Frontiers in Microbiology, vol. 5, 2015. View at Publisher · View at Google Scholar
  • Murugaiyan Gopalpp. 93–119, 2015. View at Publisher · View at Google Scholar
  • Ting Xia, Xing-feng Zheng, Bao-hua Qian, He Fang, Jun-jie Wang, Lan-ling Zhang, Ya-fei Pang, Ju Zhang, Xiao-qing Wei, Zhao-fan Xia, and Dong-bao Zhao, “Plasma Interleukin-37 Is Elevated in Patients with Rheumatoid Arthritis: Its Correlation with Disease Activity and Th1/Th2/Th17-Related Cytokines,” Disease Markers, vol. 2015, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  • Xin Wang, Xiangna Cai, Lan Chen, Duanmin Xu, and Jilin Li, “The Evaluation of Plasma and Leukocytic IL-37 Expression in Early Inflammation in Patients with Acute ST-Segment Elevation Myocardial Infarction after PCI,” Mediators of Inflammation, vol. 2015, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  • Qishi Zheng, Guangying Cui, Jianing Chen, Hainv Gao, Yingfeng Wei, Toshimitsu Uede, Zhi Chen, and Hongyan Diao, “Regular Exercise Enhances the Immune Response Against Microbial Antigens Through Up-Regulation of Toll-like Receptor Signaling Pathways,” Cellular Physiology And Biochemistry, vol. 37, no. 2, pp. 735–746, 2015. View at Publisher · View at Google Scholar
  • Arseniy E. Yuzhalin, and Anton G. Kutikhin, “Interleukin-1 Superfamily and Cancer,” Interleukins in Cancer Biology, pp. 17–61, 2015. View at Publisher · View at Google Scholar
  • Giulio Cavalli, Marije Koenders, Vassili Kalabokis, Jihye Kim, Aik Choon Tan, Cecilia Garlanda, Alberto Mantovani, Lorenzo Dagna, Leo A. B. Joosten, and Charles A. Dinarello, “Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation,” Rheumatology, pp. kew325, 2016. View at Publisher · View at Google Scholar
  • Qing Lin, Guo-Tong Xu, Tianshu Yang, Mengmeng Zhao, Yongguang Hu, Ying Yu, Jianhua Yang, and Shao Bo Su, “Involvement of IL-37 in the pathogenesis of proliferative diabetic retinopathy,” Investigative Ophthalmology and Visual Science, vol. 57, no. 7, pp. 2955–2962, 2016. View at Publisher · View at Google Scholar
  • Charles A. Dinarello, Claudia Nold-Petry, Marcel Nold, Mayumi Fujita, Suzhao Li, Soohyun Kim, and Philip Bufler, “Suppression of innate inflammation and immunity by interleukin-37,” European Journal of Immunology, vol. 46, no. 5, pp. 1067–1081, 2016. View at Publisher · View at Google Scholar
  • Shi-xiong Ding, Jian-bo Ma, Yao-ren Hu, Ai-rong Hu, Qiang Shen, and Guo-shen Gao, “Outcomes of Interferon/Ribavirin Therapy in Patients with HCV Defined by Expression of Plasma Soluble Human Leukocyte Antigen-G but Not IL-37,” Medical Science Monitor, vol. 22, pp. 1398–1402, 2016. View at Publisher · View at Google Scholar
  • Rajamanickam Anuradha, Saravanan Munisankar, Yukti Bhootra, Jeeva Jagannathan, Chandrakumar Dolla, Paul Kumaran, Kui Shen, Thomas B. Nutman, and Subash Babu, “Systemic Cytokine Profiles in Strongyloides stercoralis Infection and Alterations following Treatment,” Infection And Immunity, vol. 84, no. 2, pp. 425–431, 2016. View at Publisher · View at Google Scholar
  • Da-Wei Wang, Chun-Ting Wang, Ning Dong, Yao Wu, Xiao-Mei Zhu, and Yong-Ming Yao, “Interleukin-37 Enhances the Suppressive Activity of Naturally Occurring CD4 + CD25 + Regulatory T Cells,” Scientific Reports, vol. 6, 2016. View at Publisher · View at Google Scholar
  • Mark R. Wakefield, Qian Bai, Yujiang Fang, Vivi A. Ding, Ziwen Zhu, Alyse A. Mantz, and Huaping Xiao, “The Role of IL-37 in Non-Cancerous Diseases,” Pathology & Oncology Research, 2016. View at Publisher · View at Google Scholar
  • Marina Coll-Miró, Isaac Francos-Quijorna, Eva Santos-Nogueira, Abel Torres-Espin, Philip Bufler, Charles A. Dinarello, and Rubèn López-Vales, “Beneficial effects of IL-37 after spinal cord injury in mice,” Proceedings of the National Academy of Sciences, vol. 113, no. 5, pp. 1411–1416, 2016. View at Publisher · View at Google Scholar
  • Fangyuan Zhang, Zhengfeng Zhu, Kai Meng, Xiaoqi Zhao, Yuzhou Liu, Xiaobo Mao, Haitao Sun, Huairui Shi, Yuzhen Wei, Wenbin Xu, Quan Luo, Ruirui Zhu, Yi Mao, Peng Cheng, Qiutang Zeng, Kunwu Yu, Yucheng Zhong, and Xin Su, “Interleukin-37 and dendritic cells treated with interleukin-37 plus troponin I ameliorate cardiac remodeling after myocardial infarction,” Journal of the American Heart Association, vol. 5, no. 12, 2016. View at Publisher · View at Google Scholar
  • Geerte Hoeke, P. Padmini Khedoe, Janna van Diepen, Karin Pike-Overzet, Britt van de Ven, Nadia Vazirpanah, Isabel Mol, Pieter Hiemstra, Frank Staal, Rinke Stienstra, Mihai Netea, Charles Dinarello, Patrick Rensen, and Jimmy Berbée, “The Effects of Selective Hematopoietic Expression of Human IL-37 on Systemic Inflammation and Atherosclerosis in LDLr-Deficient Mice,” International Journal of Molecular Sciences, vol. 18, no. 8, pp. 1672, 2017. View at Publisher · View at Google Scholar
  • Ayoub Abulkhir, Suzanne Samarani, Devendra Amre, Elie Haddad, Daniel Sinnett, Ali Ahmad, Michel Duval, Jean-Marie Leclerc, and Caroline Diorio, “A protective role of IL-37 in cancer: A new hope for cancer patients,” Journal of Leukocyte Biology, vol. 101, no. 2, pp. 395–406, 2017. View at Publisher · View at Google Scholar
  • Susanne Pfeiler, Holger Winkels, Malte Kelm, and Norbert Gerdes, “IL-1 family cytokines in cardiovascular disease,” Cytokine, 2017. View at Publisher · View at Google Scholar
  • Felix Grabherr, Christoph Grander, Timon E. Adolph, Verena Wieser, Lisa Mayr, Barbara Enrich, Sophie Macheiner, Moris Sangineto, Andreas Reiter, Andre Viveiros, Heinz Zoller, Philip Bufler, Alexander R. Moschen, Charles A. Dinarello, and Herbert Tilg, “Ethanol-mediated suppression of IL-37 licenses alcoholic liver disease,” Liver International, 2017. View at Publisher · View at Google Scholar
  • A.E. Alagbe, A.S. Justo Junior, L.P. Ruas, W.V. Tonassé, R.M. Santana, T.H.C. Batista, I.F. Domingos, A.S. Araujo, M.A.C. Bezerra, M.N.N. Santos, and M.H.S.L. Blotta, “Interleukin-27 and interleukin-37 are elevated in sickle cell anemia patients and inhibit in vitro secretion of interleukin-8 in neutrophils and monocytes,” Cytokine, 2017. View at Publisher · View at Google Scholar
  • Y Li, M Zhao, C Guo, H Chu, W Li, X Chen, X Wang, Y Li, Y Jia, S Koussatidjoa, F Zhu, J Wang, X Wang, Q Wang, W Zhao, Y Shi, W Chen, and L Zhang, “Intracellular mature IL-37 suppresses tumor metastasis via inhibiting Rac1 activation,” Oncogene, 2017. View at Publisher · View at Google Scholar
  • Lina Zhang, Jie Zhang, and Peng Gao, “The potential of interleukin-37 as an effective therapeutic agent in asthma,” Respiratory Research, vol. 18, no. 1, 2017. View at Publisher · View at Google Scholar
  • Yong-Chao Li, Gang Chi, Fang Guo, Gui-Mei Zhang, Zuo-Hua Feng, Jiu-Ming Zou, Chao Luo, Yu Shu, Jing Luo, Jian Qin, Yu Wang, Dong Li, and Shan-Shan Wang, “Circulating tumor cells promote the metastatic colonization of disseminated carcinoma cells by inducing systemic inflammation,” Oncotarget, vol. 8, no. 17, pp. 28418–28430, 2017. View at Publisher · View at Google Scholar
  • Eline Kuipers, Andrea van Dam, Dov Ballak, Ellemiek de Wit, Charles Dinarello, Rinke Stienstra, Janna van Diepen, Patrick Rensen, and Mariëtte Boon, “IL-37 Expression Reduces Lean Body Mass in Mice by Reducing Food Intake,” International Journal of Molecular Sciences, vol. 19, no. 8, pp. 2264, 2018. View at Publisher · View at Google Scholar
  • Gang Chi, Xin-Xia Feng, Ying-Xia Ru, Ting Xiong, Yuan Gao, Han Wang, Zhen-Long Luo, Ran Mo, Fang Guo, Yong-Pei He, Gui-Mei Zhang, De-An Tian, and Zuo-Hua Feng, “TLR2/4 ligand-amplified liver inflammation promotes initiation of autoimmune hepatitis due to sustained IL-6/IL-12/IL-4/IL-25 expression,” Molecular Immunology, vol. 99, pp. 171–181, 2018. View at Publisher · View at Google Scholar
  • Jing Zhu, Jie Dong, Lu Ji, Peiyong Jiang, Ting Fan Leung, Dehua Liu, Lai Guan Ng, Miranda Sin-Man Tsang, Delong Jiao, Christopher Wai-Kei Lam, and Chun-Kwok Wong, “Anti-Allergic Inflammatory Activity of Interleukin-37 Is Mediated by Novel Signaling Cascades in Human Eosinophils,” Frontiers in Immunology, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Mingsheng Zhao, Yulan Li, Chun Guo, Liyang Wang, Hongxia Chu, Faliang Zhu, Yan Li, Xiaoyan Wang, Qun Wang, Wei Zhao, Yongyu Shi, WanJun Chen, and Lining Zhang, “IL-37 isoform D downregulates pro-inflammatory cytokines expression in a Smad3-dependent manner,” Cell Death & Disease, vol. 9, no. 6, 2018. View at Publisher · View at Google Scholar
  • Ramatu Bello, Voon Chin, Mohammad Abd Rachman Isnadi, Roslaini Abd Majid, Maizaton Atmadini Abdullah, Tze Lee, Zainul Amiruddin Zakaria, Mohd Hussain, and Rusliza Basir, “The Role, Involvement and Function(s) of Interleukin-35 and Interleukin-37 in Disease Pathogenesis,” International Journal of Molecular Sciences, vol. 19, no. 4, pp. 1149, 2018. View at Publisher · View at Google Scholar
  • Luis Sendra, María Herrero, and Salvador Aliño, “Translational Advances of Hydrofection by Hydrodynamic Injection,” Genes, vol. 9, no. 3, pp. 136, 2018. View at Publisher · View at Google Scholar